%0 Journal Article
%T Induction therapy in heart transplantation
%A H. Lehmkuhl
%A M. Dandel
%A N. Hiemann
%A C. Knosalla
%J Transplantationsmedizin
%D 2011
%I Pabst Science Publishers
%X Survival after heart transplantation (HTx) has improved considerably over the past 20 years. Half of all patients now live more than 13 years, and approximately more than 25% live more than 20 years. The long-term results of cardiac transplantation have continued to improve due to improved peri-operative care and immunosuppression regimens. The risk for acute rejection is highest early after HTx and therefore many transplant centers use a strategy of peri-operative induction therapy in order to provide a rapid and effective protection against acute allograft rejection (1,2).
%K heart transplantation
%K immunosuppression
%K induction therapy
%U http://www.transplantation.de/fileadmin/transplantation/txmedizin/txmedizin_2011_3/08_lehmkuhl.pdf